SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

Clinical trial NCT02057107 · COMPLETED

Trial details

NCT number: NCT02057107
Sponsor: Heath Skinner
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck Cancer

Start date: 2013-07-03
Primary completion: 2019-03-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.